JDR Woodhead Publishing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baron, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baron, S.
J Dent Res 82(4): 252, 2003
© 2003 International and American Associations for Dental Research


GUEST EDITORIAL

Smallpox: The Main Site of Transmission is the Oropharynx

Samuel Baron

Department of Microbiology & Immunology, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1019; sabaron{at}utmb.edu

KEY WORDS: smallpox • transmission • shedding • oropharynx

The threat of a bioterrorist attack with smallpox virus is real because immunity of our population is low (Cohen, 2001). In response to this threat, interruption of oral shedding may be an important area for study. Often unrecognized is that infected persons shed most smallpox virus from the epithelium of the naso-oropharynx and salivary glands (Dixon, 1962; Suvakovic and Kecmanovic, 1976; Fenner et al., 1988; Henderson et al., 1999; Smee et al., 2001; Whitby et al., 2002). The titer of infectious virus shed from the naso-oropharynx is 106-108 compared with 10- to 100-fold lower titers in the lungs and the skin during natural infection. The high levels of virus in the oropharynx result from virus multiplication in the mucosa after viremic dissemination into that site, which occurs at the same time as dissemination to the skin and lungs. Oropharyngeal shedding theoretically can be controlled by several measures, such as isolation procedures (Henderson et al., 1999), immunization (Hochstein-Mintzel et al., 1972), natural antiviral substances in saliva (Baron, 2001), antiviral drugs such as Cidofovir (Smee et al., 2001), antibody, and disinfection of air (Henderson et al., 1999). In addition, practical and immediate interruption of oropharyngeal shedding may be accomplished by topical antiviral agents such as microbicides (Baron et al., 2001). Decisive studies of the mechanisms of shedding and techniques to decrease oropharyngeal shedding of poxviruses were curtailed when smallpox was eliminated about 30 years ago (Henderson et al., 1999; Cohen, 2001). It may be reasonable to conclude that resumption of studies of oropharyngeal shedding of poxviruses and methods for interruption should be given high priority by scientists in the dental and infectious disease areas of research.

Received December 16, 2002; Accepted December 17, 2002

REFERENCES

Baron S (2001). Oral transmission of HIV, a rarity: emerging hypotheses. J Dent Res 80:1602–1604.[Free Full Text]

Baron S, Poast J, Nguyen D, Cloyd M (2001). Practical prevention of vaginal and rectal transmission of HIV by adapting the oral defense: use of commercial lubricants. AIDS Res Hum Retroviruses 17:997–1002.[ISI][Medline]

Cohen J (2001). Bioterrorism. Smallpox vaccinations: how much protection remains? Science 294:985.[Free Full Text]

Dixon CW (1962). Smallpox. London, England: J. & A. Churchill, Ltd.

Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID (1988). Smallpox and its eradication. Geneva, Switzerland: World Health Organization.

Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, et al. (1999). Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. J Am Med Assoc 281:2127–2137.[Abstract/Free Full Text]

Hochstein-Mintzel V, Huber HC, Stickl H (1972). Oral and nasal immunization with Poxvirus vacciniae. 3. Animal experiments. Zentralbl Bakteriol 156:30–96.

Smee DF, Bailey KW, Sidwell RW (2001). Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir. Antivir Chem Chemother 12:71–76.[ISI][Medline]

Suvakovic V, Kecmanovic M (1976). Lesions of visible mucous membranes during the course of variola. Studies of 118 patients in the epidemics in the year 1972. Srp Arh Celok Lek 104:513–526.[Medline]

Whitby M, Street AC, Ruff TA, Fenner F (2002). Biological agents as weapons. 1: Smallpox and botulism. Med J Aust 176:431–433.[ISI][Medline]




This article has been cited by other articles:


Home page
J. Virol.Home page
P. D. Vermeer, J. McHugh, T. Rokhlina, D. W. Vermeer, J. Zabner, and M. J. Welsh
Vaccinia Virus Entry, Exit, and Interaction with Differentiated Human Airway Epithelia
J. Virol., September 15, 2007; 81(18): 9891 - 9899.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
J. Rinaggio and M. Glick
The smallpox vaccine: An update for oral health care professionals
J Am Dent Assoc, April 1, 2006; 137(4): 452 - 460.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baron, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baron, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
IADR Journals Advances in Dental Research ®
Journal of Dental Research ® Critical Reviews (1990-2004)